uterine fibroids

ObsEva will cut staff by 70% after FDA setback for uterine fibroids candidate linzagolix
Fierce Pharma
Tue, 09/13/22 - 07:53 pm
ObsEva
uterine fibroids
linzagolix
layoffs
FDA setback leads women’s health biotech ObsEva to give up on uterine fibroids drug
MedCity News
Wed, 07/27/22 - 06:43 pm
ObsEva
uterine fibroids
linzagolix
FDA
Gedeon Richter gets NICE nod for uterine fibroids drug Ryeqo
Pharmaforum
Fri, 05/13/22 - 11:41 am
Gedeon Richter
NICE
uterine fibroids
Ryeqo
ObsEva files uterine fibroid drug in US, chasing AbbVie, Myovant
Pharmaforum
Wed, 09/15/21 - 10:46 am
ObsEva
uterine fibroids
AbbVie
Myovant
FDA
linzagolix
Myovant and Pfizer's uterine fibroids med scores FDA nod, setting up showdown with AbbVie
Fierce Pharma
Wed, 05/26/21 - 11:58 pm
Myovant Sciences
Pfizer
FDA
Relugolix
uterine fibroids
Myovant/Pfizer's Relugolix Combo Therapy Shows Sustained Clinical Benefit In Uterine Fibroids
Benzinga
Wed, 03/24/21 - 10:16 am
Myovant
Pfizer
clinical trials
Relugolix
uterine fibroids
Obseva shows why red flags are worth heeding
EP Vantage
Tue, 07/7/20 - 10:26 am
ObsEva
uterine fibroids
clinical trials
linzagolix
AbbVie Wins First FDA Approval of Drug to Treat Uterine Fibroid Bleeds
Xconomy
Sat, 05/30/20 - 08:00 pm
AbbVie
FDA
uterine fibroids
Elagolix
Oriahnn
Upcoming events – Fibroid data for Obseva, as Inventiva turns to Nash
EP Vantage
Fri, 03/6/20 - 10:49 am
ObsEva
uterine fibroids
clinical trials
NASH
Inventiva
lanifibranor
Myovant's Uterine Fibroid Drug Relugolix Produces Positive Data in a Long-Term Study
Motley Fool
Mon, 02/10/20 - 11:27 pm
Myovant Sciences
Relugolix
uterine fibroids
clinical trials
Upcoming events – Pfizer's abrocitinib and Myovant's relugolix
EP Vantage
Sat, 01/11/20 - 12:01 am
Pfizer
abrocitinib
Dupixent
Sanofi
Myovant
Relugolix
uterine fibroids
Upcoming events – Obseva's first fibroid foray and Newron's test in Retts
EP Vantage
Fri, 09/6/19 - 10:12 am
clinical trials
ObsEva
uterine fibroids
linzagolix
Newron Pharma
Rett Syndrome
Myovant's uterine fibroid drug looks competitive in PhIII — but can they vanquish mighty AbbVie?
Endpoints
Tue, 07/23/19 - 10:05 am
Myovant
uterine fibroids
Relugolix
AbbVie
Elagolix
Myovant hits goal in uterine fibroid phase 3, teeing up AbbVie showdown
Fierce Biotech
Tue, 05/14/19 - 09:26 am
Myovant Sciences
Relugolix
clinical trials
uterine fibroids
AbbVie
Elagolix
In the wake of deep R&D cuts, Bayer flags safety concerns for a top PhIII drug
Endpoints
Wed, 12/5/18 - 09:50 am
Bayer
layoffs
R&D
vilaprisan
uterine fibroids
AbbVie's Orilissa makes its uterine fibroids case with double phase 3 win
Fierce Pharma
Thu, 11/15/18 - 11:39 pm
AbbVie
Orilissa
FDA
uterine fibroids
Neurocrine
AbbVie extension study tees up elagolix for uterine fibroids
Biopharma Dive
Thu, 08/23/18 - 04:30 pm
AbbVie
uterine fibroids
Elagolix
clinical trials
Allergan may not lose much from latest FDA rejection
Biopharma Dive
Wed, 08/22/18 - 11:16 pm
Allergan
FDA
uterine fibroids
Esmya
FDA Clears Gynesonics to Market Incision Free Fibroid Ablation System
CP Wire
Wed, 08/22/18 - 09:37 am
Gynesonics
Sonata System
uterine fibroids
devices
FDA Clears Gynesonics to Market Incision Free Fibroid Ablation System
Wed, 08/22/18 - 09:34 am
Gynesonics
Sonata System
uterine fibroids

Pages